{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:25:08Z","timestamp":1788279908775,"version":"build-2803163510"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["52 \/22\/2020- BIO \/ BMS"],"award-info":[{"award-number":["52 \/22\/2020- BIO \/ BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG \/2018\/000458"],"award-info":[{"award-number":["CRG \/2018\/000458"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejphar.2026.179194","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T05:53:20Z","timestamp":1785995600000},"page":"179194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Terbutaline selectively reduces non-fibrillar \u03b1-synuclein aggregates and oxidative stress without affecting liquid\u2013liquid phase separation or fibrillogenesis"],"prefix":"10.1016","volume":"1032","author":[{"given":"Soumojit","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimisha A.","family":"Mavlankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asish","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-444X","authenticated-orcid":false,"given":"Ipsita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179194_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-genet-112618-043527","article-title":"Liquid\u2013liquid phase separation in disease","volume":"53","author":"Alberti","year":"2019","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ejphar.2026.179194_bib2","doi-asserted-by":"crossref","first-page":"17197","DOI":"10.1074\/jbc.M115.708230","article-title":"Cellular redox systems impact the aggregation of Cu, Zn superoxide dismutase linked to familial amyotrophic lateral sclerosis","volume":"291","author":"\u00c1lvarez-Zaldiernas","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/jb\/mvae012","article-title":"C-terminal truncation is a prominent post-translational modification of human erythrocyte \u03b1-synuclein","volume":"175","author":"Amagai","year":"2024","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejphar.2026.179194_bib4","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jmb.2020.03.004","article-title":"Liquid\u2013liquid phase separation and its mechanistic role in pathological protein aggregation","volume":"432","author":"Babinchak","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.179194_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.ejphar.2026.179194_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34759-z","article-title":"Aggregated SOD1 causes selective death of cultured human motor neurons","volume":"8","author":"Benkler","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179194_bib7","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1039\/D5BM01817J","article-title":"Betulinic acid exacerbates biomolecular condensation of \u03b1-synuclein: possible role in parkinson's disease","volume":"14","author":"Biswas","year":"2026","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejphar.2026.179194_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s42004-026-02032-4","article-title":"Modulation of biomolecular condensation of alpha-synuclein variants by eprodisate","author":"Biswas","year":"2026","journal-title":"Commun. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jmb.2010.10.027","article-title":"The Anti-Parkinsonian drug selegiline delays the nucleation phase of \u03b1-synuclein aggregation leading to the formation of nontoxic species","volume":"405","author":"Braga","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.179194_bib10","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1021\/acs.jproteome.7b00025","article-title":"Quantitative analysis of human red blood cell proteome","volume":"16","author":"Bryk","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejphar.2026.179194_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1471-4159.2001.00021.x","article-title":"The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with lewy bodies and Parkinson's disease","volume":"76","author":"Campbell","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.179194_bib12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1096\/fj.04-3437fje","article-title":"Dopamine promotes \u03b1\u2010synuclein aggregation into SDS\u2010 resistant soluble oligomers via a distinct folding pathway","volume":"19","author":"Cappai","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2026.179194_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00018-022-04166-9","article-title":"Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies","volume":"79","author":"Cascella","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2026.179194_bib14","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/mt.2015.157","article-title":"Inhibition of aggregation of mutant huntingtin by nucleic acid aptamers in vitro and in a yeast model of Huntington's disease","volume":"23","author":"Chaudhary","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2026.179194_bib15","first-page":"E1994","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejphar.2026.179194_bib16","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1021\/acs.jpcb.2c03676","article-title":"Exploring the interplay between disordered and ordered oligomer channels on the aggregation energy landscapes of alpha-synuclein","volume":"126","author":"Chen","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejphar.2026.179194_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s10020-025-01208-3","article-title":"The interplay of iron, oxidative stress, and alpha-synuclein in Parkinson's disease progression","volume":"31","author":"Chen","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179194_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/ijms26010053","article-title":"Beyond misfolding: a new paradigm for the relationship between protein folding and aggregation","volume":"26","author":"Choi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179194_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179194_bib20","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1038\/s41467-024-47585-x","article-title":"Pharmacological inhibition of \u03b1-synuclein aggregation within liquid condensates","volume":"15","author":"Dada","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179194_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/ars.2015.6343","article-title":"Alpha- synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease","volume":"24","author":"Deas","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejphar.2026.179194_bib22","doi-asserted-by":"crossref","first-page":"14941","DOI":"10.1074\/jbc.M109.080390","article-title":"Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of \u03b1-synuclein and \u03b2-amyloid and protect against amyloid-induced toxicity","volume":"285","author":"Di Giovanni","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-physchem-071819-113553","article-title":"Biomolecular phase separation: from molecular driving forces to macroscopic properties","volume":"71","author":"Dignon","year":"2020","journal-title":"Annu. Rev. Phys. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib24","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/srep02540","article-title":"A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson's disease","volume":"3","author":"Foulds","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179194_bib25","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179194_bib26","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","article-title":"Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models","volume":"34","author":"Games","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179194_bib27","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.3390\/ijms21218043","article-title":"Multiplicity of \u03b1-synuclein aggregated species and their possible roles in disease","volume":"21","author":"Gracia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179194_bib28","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1021\/acschemneuro.5c00160","article-title":"Divalent and trivalent metallic ions differentially affect alpha-synuclein aggregation","volume":"16","author":"Graves","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179194_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s42003-025-07599-7","article-title":"Evidence from a mouse model supports repurposing an anti-asthmatic drug, bambuterol, against Alzheimer's disease by administration through an intranasal route","volume":"8","author":"Groo","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejphar.2026.179194_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36402","article-title":"Cryo- EM structure of alpha-synuclein fibrils","volume":"7","author":"Guerrero-Ferreira","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2026.179194_bib31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bcp.2013.12.023","article-title":"Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins","volume":"88","author":"Guerrero-Mu\u00f1oz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179194_bib32","article-title":"Inhibitory effects of magnolol and honokiol on human calcitonin aggregation","volume":"5","author":"Guo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179194_bib33","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1021\/jacs.2c13647","article-title":"Liquid\u2013liquid phase separation modifies the dynamic properties of intrinsically disordered proteins","volume":"145","author":"Guseva","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2026.179194_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1021\/acs.biochem.6b01060","article-title":"Site-specific fluorescence polarization for studying the disaggregation of \u03b1-synuclein fibrils by small molecules","volume":"56","author":"Haney","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2026.179194_bib35","first-page":"282","article-title":"Observation of an \u03b1-synuclein liquid droplet state and its maturation into lewy body-like assemblies","volume":"13","author":"Hardenberg","year":"2021","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179194_bib36","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/1873-3468.14361","article-title":"\u03b1\u2010Synuclein phase separation and amyloid aggregation are modulated by c\u2010terminal truncations","volume":"596","author":"Huang","year":"2022","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2026.179194_bib37","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1021\/acschemneuro.7b00261","article-title":"Comparison of \u03b1-synuclein fibril inhibition by four different amyloid inhibitors","volume":"8","author":"Jha","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179194_bib38","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1021\/acschemneuro.5b00158","article-title":"Understanding caffeine's role in attenuating the toxicity of \u03b1-synuclein aggregates: implications for risk of Parkinson's disease","volume":"6","author":"Kardani","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179194_bib39","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.bbadis.2017.02.002","article-title":"Nicotine slows down oligomerisation of \u03b1-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease","volume":"1863","author":"Kardani","year":"2017","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2026.179194_bib40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179194_bib41","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0006-3495(03)74550-0","article-title":"A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy","volume":"85","author":"Khurana","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2026.179194_bib42","doi-asserted-by":"crossref","first-page":"16257","DOI":"10.1039\/C6CP07774A","article-title":"Model membrane size-dependent amyloidogenesis of Alzheimer's amyloid-\u03b2 peptides","volume":"19","author":"Kinoshita","year":"2017","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejphar.2026.179194_bib43","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1021\/acschemneuro.8b00250","article-title":"Oligomer diversity during the aggregation of the repeat region of tau","volume":"9","author":"Kjaergaard","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179194_bib44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179194_bib45","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chembiol.2004.08.025","article-title":"Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils","volume":"11","author":"Li","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2026.179194_bib46","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/foods13091287","article-title":"Curcumin inhibits \u03b1-synuclein aggregation by acting on liquid\u2013liquid phase transition","volume":"13","author":"Li","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.ejphar.2026.179194_bib47","article-title":"Receptor-dependent endocytosis mediates \u03b1- synuclein oligomer transport into red blood cells","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2026.179194_bib48","doi-asserted-by":"crossref","first-page":"8748","DOI":"10.1038\/s41467-024-53086-8","article-title":"\u03b2-synuclein regulates the phase transitions and amyloid conversion of \u03b1-synuclein","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179194_bib49","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1016\/j.bbadis.2018.10.003","article-title":"C-terminal truncation exacerbates the aggregation and cytotoxicity of \u03b1-synuclein: a vicious cycle in Parkinson's disease","volume":"1864","author":"Ma","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2026.179194_bib50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.aar7366","article-title":"RNA buffers the phase separation behavior of prion-like RNA binding proteins","volume":"360","author":"Maharana","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179194_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40478-017-0470-4","article-title":"Transmission of \u03b1-synuclein-containing erythrocyte- derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?","volume":"5","author":"Matsumoto","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejphar.2026.179194_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/cnma.202200368","article-title":"Amyloid\u2010inspired peptide self\u2010 assembly\/disassembly as intervened by gold nanoparticles and polydopamine coating to dictate spatiotemporal organization","volume":"8","author":"Mavlankar","year":"2022","journal-title":"ChemNanoMat"},{"key":"10.1016\/j.ejphar.2026.179194_bib53","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1039\/D4TB00810C","article-title":"Maneuvering the mineralization of self-assembled peptide nanofibers for designing mechanically-stiffened self-healable composites toward bone-mimetic ECM","volume":"12","author":"Mavlankar","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejphar.2026.179194_bib54","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/biom11101419","article-title":"Structural and functional insights into \u03b1-synuclein fibril polymorphism","volume":"11","author":"Mehra","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.179194_bib55","doi-asserted-by":"crossref","first-page":"12975","DOI":"10.1074\/jbc.RA118.004267","article-title":"Glycosaminoglycans have variable effects on \u03b1-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils","volume":"293","author":"Mehra","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib56","doi-asserted-by":"crossref","first-page":"19213","DOI":"10.1074\/jbc.M110551200","article-title":"Biochemical characterization of the core structure of \u03b1-synuclein filaments","volume":"277","author":"Miake","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41557-020-0452-1","article-title":"Dynamics of oligomer populations formed during the aggregation of Alzheimer's A\u03b242 peptide","volume":"12","author":"Michaels","year":"2020","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib58","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/acs.chemrev.3c00622","article-title":"Macromolecular crowding, phase separation, and homeostasis in the orchestration of bacterial cellular functions","volume":"124","author":"Monterroso","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2026.179194_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2015.12.013","article-title":"Alpha-synuclein dimerization in erythrocytes of gaucher disease patients: correlation with lipid abnormalities and oxidative stress","volume":"613","author":"Moraitou","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2026.179194_bib60","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1039\/D3CS01065A","article-title":"Protein misfolding and amyloid nucleation through liquid\u2013liquid phase separation","volume":"53","author":"Mukherjee","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejphar.2026.179194_bib61","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fnins.2017.00278","article-title":"Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes","volume":"11","author":"Mustapic","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179194_bib62","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1021\/bi002555c","article-title":"Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism","volume":"40","author":"Nielsen","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2026.179194_bib63","doi-asserted-by":"crossref","first-page":"11845","DOI":"10.1002\/chem.202101592","article-title":"Remodeling of the fibrillation pathway of \u03b1\u2010synuclein by interaction with antimicrobial peptide LL\u2010III","volume":"27","author":"Oliva","year":"2021","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejphar.2026.179194_bib64","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/febs.70321","article-title":"M14 substitutions in exanatide modulate alpha-synuclein aggregation","volume":"293","author":"Panuganti","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2026.179194_bib65","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1080\/07391102.2020.1856721","article-title":"Oligomers, fibrils and aggregates formed by alpha-synuclein: role of solution conditions","volume":"40","author":"Panuganti","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejphar.2026.179194_bib66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2017.11.012","article-title":"Alpha- synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease","volume":"672","author":"Papagiannakis","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2026.179194_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy- drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2026.179194_bib68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41582-024-01043-w","article-title":"Alpha-synuclein pathology as a target in neurodegenerative diseases","volume":"21","author":"Park","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2026.179194_bib69","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"\u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.179194_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mcn.2014.08.002","article-title":"Linking \u03b1-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells","volume":"62","author":"Perfeito","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179194_bib71","doi-asserted-by":"crossref","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism","volume":"112","author":"Prusiner","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejphar.2026.179194_bib72","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","article-title":"\u03b1-Synuclein aggregation nucleates through liquid\u2013liquid phase separation","volume":"12","author":"Ray","year":"2020","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib73","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/ajh.23796","article-title":"Genetic deletion of the GATA1-regulated protein \u03b1-synuclein reduces oxidative stress and nitric oxide synthase levels in mature erythrocytes","volume":"89","author":"Renella","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejphar.2026.179194_bib74","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/ijms15011040","article-title":"In vitro phosphorylation does not influence the aggregation kinetics of WT \u03b1-synuclein in contrast to its phosphorylation mutants","volume":"15","author":"Schreurs","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179194_bib75","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbagen.2012.04.021","article-title":"Differential inhibition of \u03b1-synuclein oligomeric and fibrillar assembly in Parkinson's disease model by cinnamon extract","volume":"1820","author":"Shaltiel-Karyo","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2026.179194_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10216","article-title":"Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups","volume":"6","author":"Soeda","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179194_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/srep40859","article-title":"The chaperonin CCT inhibits assembly of \u03b1-synuclein amyloid fibrils by a specific, conformation-dependent interaction","volume":"7","author":"Sot","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179194_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/cells13232026","article-title":"Interplay between metabolic pathways and increased oxidative stress in human red blood cells","volume":"13","author":"Spinelli","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179194_bib79","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1074\/jbc.M802223200","article-title":"Serine 129 phosphorylation of \u03b1-synuclein induces unfolded protein response-mediated cell death","volume":"283","author":"Sugeno","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101978","article-title":"Truncation or proteolysis of \u03b1-synuclein in Parkinsonism","volume":"90","author":"Suthar","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2026.179194_bib81","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: a vehicle for the expression of recombinant proteins","volume":"51","author":"Thomas","year":"2005","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2026.179194_bib82","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-019-0155-y","article-title":"Erythrocytic alpha-synuclein as a potential biomarker for Parkinson's disease","volume":"8","author":"Tian","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejphar.2026.179194_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.jct.2022.106951","article-title":"Inhibition of \u03b1-synuclein fibrillation by natural polyphenols: thermodynamic and biophysical aspects","volume":"177","author":"Tinku","year":"2023","journal-title":"J. Chem. Thermodyn."},{"key":"10.1016\/j.ejphar.2026.179194_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.151195","article-title":"Hydroxycinnamic acids mediated modulation of \u03b1-synuclein fibrillation: biophysical insights","volume":"744","author":"Tinku","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2026.179194_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110470","article-title":"Mechanism of flavonoid myricetin modulated aggregation in \u03b1-synuclein and its familial mutants E46K and A30P","volume":"770","author":"Tinku","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2026.179194_bib86","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.tibs.2019.03.005","article-title":"Stochasticity of biological soft matter: emerging concepts in intrinsically disordered proteins and biological phase separation","volume":"44","author":"Turoverov","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2026.179194_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2025.04.008","article-title":"Fibril-seeded animal models of synucleinopathies: pathological mechanisms, disease modeling, and therapeutic implications","volume":"216","author":"Uemura","year":"2025","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejphar.2026.179194_bib88","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib89","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41570-024-00635-w","article-title":"The role of biomolecular condensates in protein aggregation","volume":"8","author":"Visser","year":"2024","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.ejphar.2026.179194_bib90","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","article-title":"Changes in properties of serine 129 phosphorylated \u03b1-synuclein with progression of lewy-type histopathology in human brains","volume":"240","author":"Walker","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2026.179194_bib91","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41392-021-00678-1","article-title":"Liquid\u2013liquid phase separation in human health and diseases","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179194_bib92","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nchem.2803","article-title":"Phase behaviour of disordered proteins underlying low density and high permeability of liquid organelles","volume":"9","author":"Wei","year":"2017","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejphar.2026.179194_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200216","article-title":"Myricetin inhibits \u03b1\u2010synuclein amyloid aggregation by delaying the liquid\u2010to\u2010solid phase transition","volume":"23","author":"Xu","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejphar.2026.179194_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139875","article-title":"Identification of novel phenolic inhibitors from traditional chinese medicine against toxic \u03b1-synuclein aggregation via regulating phase separation","volume":"297","author":"Yu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejphar.2026.179194_bib95","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.bpj.2013.04.050","article-title":"In vitro study of \u03b1-synuclein protofibrils by cryo- EM suggests a Cu2+-dependent aggregation pathway","volume":"104","author":"Zhang","year":"2013","journal-title":"Biophys. J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992600676X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992600676X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:01:11Z","timestamp":1788278471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992600676X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":95,"alternative-id":["S001429992600676X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179194","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Terbutaline selectively reduces non-fibrillar \u03b1-synuclein aggregates and oxidative stress without affecting liquid\u2013liquid phase separation or fibrillogenesis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179194"}}